Hereby, we elaborate on how the proteolytic cleavage of the amyloid precursor protein (APP) can lead to the release of Aβ in association with EVs whereafter we review the known beneficial and detrimental functions of EVs in AD. Here, APP is linked to Alzheimer disease.